4-Chloro-7-tosyl-7H-pyrrolo[2,3-d]pyrimidine (CAS 479633-63-1): A Key Intermediate in Tofacitinib Synthesis

In the ever-evolving world of pharmaceutical research, the demand for high-quality intermediates plays a crucial role in the successful synthesis of Active Pharmaceutical Ingredients (APIs). One such vital compound is 4-Chloro-7-tosyl-7H-pyrrolo[2,3-d]pyrimidine (CAS No. 479633-63-1), which serves as a key intermediate in the production of Tofacitinib — a potent Janus kinase (JAK) inhibitor used in the treatment of rheumatoid arthritis, ulcerative colitis, and psoriatic arthritis.

Understanding the Compound

4-Chloro-7-tosyl-7H-pyrrolo[2,3-d]pyrimidine is an essential heterocyclic compound with a unique molecular structure that makes it a critical building block in the Tofacitinib synthesis process. This intermediate helps ensure high yield, purity, and stability during production, supporting pharmaceutical manufacturers in maintaining consistent product quality.

Role in Tofacitinib Synthesis

Tofacitinib, marketed under the brand name Xeljanz, is a groundbreaking JAK inhibitor that has revolutionized autoimmune disease treatment. The synthesis of Tofacitinib involves multiple complex reactions, and the presence of high-purity intermediates such as 4-Chloro-7-tosyl-7H-pyrrolo[2,3-d]pyrimidine ensures process efficiency, scalability, and product reliability.

Why Choose VidgasTech

At VidgasTech, we are committed to delivering premium-quality pharmaceutical intermediates that meet global regulatory standards. Our expertise in chemical synthesis, quality control, and product customization makes us a trusted partner for leading pharmaceutical and research organizations worldwide.

We offer:

High-purity Tofacitinib intermediates

Reliable global supply and timely delivery

Customized synthesis and bulk manufacturing

Comprehensive documentation and COA support

Applications

Used as an intermediate in the synthesis of Tofacitinib

Suitable for pharmaceutical R&D and production

Ideal for academic and industrial research laboratories

Conclusion

As the pharmaceutical industry continues to expand its focus on advanced therapeutics, reliable intermediates like 4-Chloro-7-tosyl-7H-pyrrolo[2,3-d]pyrimidine (CAS 479633-63-1) are essential for efficient and cost-effective drug synthesis. Partnering with a trusted manufacturer like VidgasTech ensures consistency, compliance, and quality in every batch produced.

About VidgasTech

VidgasTech is a leading chemical and pharmaceutical intermediate manufacturer dedicated to providing innovative solutions for the pharmaceutical and biotechnology industries. With advanced facilities and a commitment to excellence, VidgasTech continues to support global pharmaceutical innovation.

🌐 Website: https://vidgastech.com/